Pacira BioSciences PCRX
NASDAQ PCRX
$25.01 -0.04 (-0.16%)
At close: Oct 1, 2026 · 4:00 PM EDT

Pacira BioSciences (PCRX) Free Cash Flow (2010 - 2026)

Updated

Pacira BioSciences (PCRX) posted Free Cash Flow of $56.12 million for Q2 2026, up 502.5% from $9.32 million a year earlier and up 144.5% from the prior quarter.

Analysis

Pacira BioSciences (PCRX) Free Cash Flow (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Pacira BioSciences was $179.52 million, up 53.3% year-over-year; for FY2025, it was $136.66 million, down 23.5% from FY2024.

  • Annual Free Cash Flow shows a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
  • In prior years, Pacira BioSciences' Free Cash Flow was $178.75 million in FY2024 (+28.1%), $139.49 million in FY2023 (+21.1%), $115.2 million in FY2022 (+44.3%) and $79.85 million in FY2021 (+103.5%).
  • Quarterly Free Cash Flow has run from a low of $9.32 million in Q2 2025 to a high of $56.96 million in Q3 2025 over five years.
  • On a year-over-year basis, Free Cash Flow increased in four of the last eight quarters, with growth averaging 51.0%.
  • The strongest year-over-year quarter for Free Cash Flow in the past five years was Q2 2026, with growth of 502.5%; the weakest was Q2 2025, with a decline of 82.0%.
  • According to Business Quant data, Free Cash Flow for the three prior quarters was $22.96 million (Q1 2026), $43.47 million (Q4 2025) and $56.96 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Pacira BioSciences 997.55 Mn 59.58 Mn 148.24 Mn 56.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.12 Mn
Mar 31, 2026 22.96 Mn
Dec 31, 2025 43.47 Mn
Sep 30, 2025 56.96 Mn
Jun 30, 2025 9.32 Mn
Mar 31, 2025 26.91 Mn
Dec 31, 2024 31.01 Mn
Sep 30, 2024 49.83 Mn
Jun 30, 2024 51.65 Mn
Mar 31, 2024 46.27 Mn
Dec 31, 2023 45.79 Mn
Sep 30, 2023 41.04 Mn
Jun 30, 2023 40.10 Mn
Mar 31, 2023 12.56 Mn
Dec 31, 2022 36.55 Mn
Sep 30, 2022 37.47 Mn
Jun 30, 2022 18.07 Mn
Mar 31, 2022 23.11 Mn
Dec 31, 2021 14.05 Mn
Sep 30, 2021 47.21 Mn
API Access

Pacira BioSciences Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=PCRX&period=max&api_key=YOUR_API_KEY